Errant Gene Therapeutics, a biotech company based in Chicago, is suing a venture capital firm and BlueBird Bio's CEO, claiming the two parties worked to 'kill' a competing medical treatment, according to The Boston Business Journal.
Pharmacy
Vertex's triple combination therapy for cystic fibrosis tops Evaluate Pharma's list of most valuable late-stage projects in the pharmaceutical industry pipeline.
In an effort to reduce provider burden and improve patient access to medication, CMS has issued a proposed rule to update e-prescribing standards, the agency announced June 17.
Rite Aid has partnered with Adobe to help drive Rite Aid's digital transformation, the drugstore chain announced June 17.
While price increases have stabilized, drug purchases remain a hospital pharmacy’s largest expenditure.
Wyoming pharmaceutical company Cody Laboratories will shut down operations in September, resulting in about 80 employees losing their jobs, according to The Powell Tribune.
Civica Rx, the hospital-owned generic drug company, is collaborating with Vizient to help reduce drug shortages.
Pfizer plans to acquire Array BioPharma in a deal valued at $11.4 billion, the companies announced June 17.
Lupin Pharmaceuticals is recalling 18,408 bottles of an antibiotic from the U.S. market.
Three major U.S. drugmakers have sued HHS in an attempt to block a rule that would require them to disclose the list price of prescription drugs in their television advertisements, according to Bloomberg.